Molecular biology of the androgen receptor.
By E. Gelmann. Journal of Clinical Oncology, 2002
985 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Genetics, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/4c3e09843e6a96271bc7632c190e34603b855e72
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Genetics
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Molecular determinants of resistance to antiandrogen therapy (2004, background): “The postulated mechanisms to explain resistance to hormone therapy can be separated into three general categorie”
- Ligand-independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone Refractory Prostate Cancer (2009, neutral): “Second, there are debilitating consequences from these treatments that must be considered when deciding whether and when to commence hormone therapy (2).”
- Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. (2006, background): “The androgen receptor (AR) plays a central role in prostate cancer development, and androgen deprivation therapy is still the standard systemic treatment for metastatic prostate cancer (1).”